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OBJECTIVES: Fluid volume optimization guided by stroke volume measurements reduces complications of
colorectal and high-risk surgeries. We studied whether dehydration or a strong hemodynamic response to
general anesthesia increases the probability of fluid responsiveness before surgery begins.
METHODS: Cardiac output, stroke volume, central venous pressure and arterial pressures were measured in 111
patients before general anesthesia (baseline), after induction and stepwise after three bolus infusions of 3 ml/
kg of 6% hydroxyethyl starch 130/0.4 (n = 86) or Ringer’s lactate (n= 25). A subgroup of 30 patients who
received starch were preloaded with 500 ml of Ringer’s lactate. Blood volume changes were estimated from the
hemoglobin concentration and dehydration was estimated from evidence of renal water conservation in urine
samples.
RESULTS: Induction of anesthesia decreased the stroke volume to 62% of baseline (mean); administration of
fluids restored this value to 84% (starch) and 68% (Ringer’s). The optimized stroke volume index was clustered
around 35-40 ml/m2/beat. Additional fluid boluses increased the stroke volume by $10% (a sign of fluid
responsiveness) in patients with dehydration, as suggested by a low cardiac index and central venous pressure
at baseline and by high urinary osmolality, creatinine concentration and specific gravity. Preloading and the
hemodynamic response to induction did not correlate with fluid responsiveness. The blood volume expanded
2.3 (starch) and 1.8 (Ringer’s) times over the infused volume.
CONCLUSIONS: Fluid volume optimization did not induce a hyperkinetic state but ameliorated the decrease in
stroke volume caused by anesthesia. Dehydration, but not the hemodynamic response to the induction, was
correlated with fluid responsiveness.
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& INTRODUCTION
Plasma volume support during surgery and intensive
care can be individualized by monitoring the stroke volume
(SV) (1,2). The anesthetist then titrates the fluid volume
required to place the patient on the top of the Frank-Starling
curve of the heart, which is reached when the SV shows
only a marginal (or no) increase in response to a higher
preload (3). During intensive care, adrenergic drugs are
often used as an adjunct to reach this goal; however, during
general surgery, bolus infusions of colloid fluids are
typically the only tool used to increase preload (4). Due to
recent concerns about the safety of colloids, researchers
have also attempted to use Ringer’s lactate for this purpose
(5).
Several reviews have focused on the clinical outcome of
patients subjected to this fluid volume optimization (1,2,4).
The method appears to have been best evaluated during
colorectal surgery. Many studies have also compared
technical methods for optimization (6), which is typically
applied after anesthesia has been induced. Little is known
about why the measurements indicate that 70% of patients
are ‘volume responders’ and thus present a functional blood
volume deficit even before surgery starts (7).
The present exploratory study assesses the influence of
preoperative volume status and the hemodynamic response
to the induction of general anesthesia on the probability of
fluid responsiveness before surgery begins. The hypotheses
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were that preoperative dehydration and/or a vigorous
hemodynamic reaction would strengthen the indication for
this optimization. For this purpose, three successive fluid
boluses of hydroxyethyl starch were infused under SV
monitoring before surgery began. A secondary aim was to
study the efficacy of Ringer’s lactate for volume optimiza-
tion and also for preloading in a subgroup of patients
receiving starch.
The preoperative fluid volume status was assessed based
on the cardiac index, central venous pressure and signs of
renal water conservation in urine samples. SV was the key
hemodynamic measure; however, it was usually expressed
as stroke volume index (SVI) to facilitate comparisons
between patients.
& MATERIALS AND METHODS
Patients
Between July 2011 and March 2013, 111 patients
(American Society of Anesthesiologists (ASA) class I or II)
scheduled for elective laparoscopic or open gastrointestinal
surgery performed under intravenous general anesthesia
were recruited to participate in the present controlled
clinical trial. The reasons for the surgery were suspected
or known gastric, colon or rectal cancer. The exclusion
criteria were liver or renal dysfunction (liver enzymes.50%
of normal or serum creatinine.50% of normal), coagulation
disturbances, obstructive pulmonary disease (airway
pressure.25 mmHg), atrial fibrillation and mental disor-
ders.
The protocol was approved by the Ethics Committee of
the First Affiliated Hospital, College of Medicine, Zhejiang
University (Hangzhou, PR China; No. 2011150, official in
charge: Zhangfei Shou). The study was registered at the
Chinese Clinical Trial Registry (http://www.chictr.org/en;
No. ChiCTR-TNRC-14004479). Written informed consent
was obtained from each study subject.
Procedure
The patients fasted overnight and no premedication was
given. When the patient entered the operating theatre,
catheterization of the left radial artery and right internal
jugular vein was performed under local anesthesia and
sedation with midazolam.
All patients received 2-4 l/min of oxygen on an open
facemask before general anesthesia was induced (at 8 AM)
with intravenous lidocaine, fentanyl and target-controlled
infusion of propofol aiming for a plasma concentration of
3-4 mg/ml. Tracheal intubation was facilitated with cisa-
tracurium (0.2 mg/kg). The patients were mechanically
ventilated at a tidal volume of 8 ml/kg and a positive end-
expiratory pressure of 3 cm H2O. The ventilation rate was
12 breaths/min or adjusted to maintain end-tidal CO2 at
36-44 mmHg. The inspiratory-expiratory ratio was 1:2.
The depth of anesthesia was monitored using a bispectral
index (BIS) sensor applied to the forehead. The signal was
recorded on a BIS monitor Model A-2000TM (Aspect
Medical Systems, Natick, MA) and the level of anesthesia
was guided to reach a BIS value between 40 and 60. The
drugs used to maintain anesthesia were 1-2% end-tidal
sevoflurane, a continuous infusion of propofol (target
plasma concentration, 2-3 mg/ml) and/or remifentanil
(0.10-0.20 mg/kg/min), with cis-atracurium included inter-
mittently as needed.
The patients’ body temperature was maintained at 35.5 C˚
or higher. One patient received i.v. ephedrine (10 mg) when
the mean arterial pressure (MAP) fell below 65 mmHg.
Volume optimization
No fluids were infused during the induction of general
anesthesia. Beginning 10 min after tracheal intubation, three
bolus infusions of either 6% hydroxyethyl starch 130/0.4
(VoluvenH; Fresenius Kabi Deutschland GmbH, Bad
Homburg, Germany) (n = 86) or Ringer’s lactate (n = 25)
were given at a volume of 3 ml/kg over 7 min via an
infusion pump (IEC 601–1; Abbott Laboratories, Chicago,
IL). The hemodynamic response was recorded 5 min after
the end of each bolus infusion. The flat recumbent body
position of the patients was maintained and surgery began
after all three optimizations had been completed. No other
fluids (except drug vehicles) were given during the study
period.
A group of 30 patients in the starch group (cases 40 to 69)
were preloaded with Ringer’s lactate (500 ml) over 2 h,
beginning 3 h before the induction of anesthesia. The
anesthesia and the research study were managed by
anesthetists who were blinded to which subjects received
preloading.
Measurements
The arterial line was connected to a FloTracTM sensor
from which data were sent to a Vigileo monitor (Software
version 3.6; Edwards Lifesciences, Irvine, CA) for analysis.
The arterial waveform pulse contour was used to calculate
stroke volume index (SVI), cardiac output (CO), cardiac
index (CI) and MAP. Monitoring also included central
venous pressure (CVP), pulse oximetry, electrocardiogra-
phy and heart rate; these data were saved digitally on a
multifunction monitor (Datex-Ohmeda, Hoevelaken, the
Netherlands).
Data on central hemodynamics were collected before and
after the induction of anesthesia, just before the first bolus
infusion was initiated and then 5 min after each of the three
bolus infusions ended. Data not used for calculations were
also obtained approximately 30 sec after tracheal intubation.
Arterial blood was withdrawn to measure the blood
hemoglobin (Hb) concentration, Hb oxygen saturation
(SO2) and oxygen tension (pO2) on a GEM Premier 3000
(Instrumentation Lab., Lexington, MA) before anesthesia
was induced and while central hemodynamic parameters
were measured after each fluid bolus. Duplicate baseline
samples ensured a CV for Hb of 1.5%.
Urine was collected via a bladder catheter inserted just
after the tracheal intubation had been performed. Samples
were sent to a certified clinical chemistry laboratory
(Shaoxing People’s Hospital Laboratory) for analysis of
osmolality (freezing point depression), creatinine concen-
tration (enzymatic method) and specific gravity (refracto-
metry). Urinary changes can mainly be attributed to
increased concentrations of metabolic waste due to kidney
stimulation to conserve water. Several indices should
ideally be assessed (8).
Calculations
The blood volume (BV) at baseline was estimated using
the following anthropometric regression equations (9):
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BV L, femalesð Þ~0:03308weight kgð Þz0:3561 height3 mð Þz0:1833
BV L,malesð Þ~0:03219weight kgð Þz0:3669height3 mð Þz0:6041
The BV expansion in response to a fluid bolus was
calculated based on the change in Hb concentration from
before (time 1) and after (time 2) the infusion (9):
DBV2{1~BV1 Hb1=Hb2ð Þ½ {BV1
The amount of fluid retained in the blood (fluid efficiency)
was given by the following equation:
Fluid retained %ð Þ~100  DBV=infused volume
Oxygen delivery (DO2) was obtained from the following:
DO2~CO: 1:39:Hb:SO2z0:003:pO2½ 
A bolus was considered to be warranted when raising the
SVI by $10% (3,4). If a bolus did not fulfill this criterion, the
SVI recorded 5 min after the previous bolus infusion ended
was utilized as the optimized SVI. If all three bolus infusions
raised the SVI by $10%, the final value was utilized as the
optimized SVI.
Statistical analysis
Normally distributed data are presented as the mean (SD)
and differences between groups were evaluated using one-
way analysis of variance (ANOVA). Data showing a skewed
distribution are reported as the median (25th–75th percentile
limits) and differences in these data were studied using the
Mann-Whitney U test. Incidence data were tested using
contingency table analysis. Changes in hemodynamic
parameters were expressed as ratios. Relationships between
parameters were analyzed using simple linear regression.
Receiver operator characteristic (ROC) curves were used to
calculate the sensitivity and specificity of selected hemody-
namic and urine parameters to predict fluid responsiveness
using IBM SPSS Statistics Version 21. Significance was
defined as p,0.05.
& RESULTS
Hydroxyethyl starch
Induction of anesthesia decreased the SVI to 64 (SD, 19)%
of baseline. At the end of the three bolus infusions, the SVI
was 84 (25)% of baseline. The optimized SVI was also 84
(21)% of baseline (Figure 1).
A high SVI at baseline was followed by a greater decrease
in SVI in response to anesthesia. The relationship was
reciprocal and persisted throughout the three bolus infu-
sions (Figure 2A–D), which increased SVI by approximately
20% (Figure 3A) to reach the optimized SVI of 40 (9) ml/
m2/beat (Figure 3B).
Preloading did not significantly affect the SVI, CI, MAP or
BV expansion; however, two of the three urinary indices of
water retention were significantly lower compared to those
of patients who did not receive preloading (median U-
osmolality of 285 versus 673 mOsmol/kg and U-creatinine
4.9 versus 8.2 mmol/l, both p,0.01).
Among the patients without preloading, those who
needed several fluid boluses to become SVI optimized were
in a higher state of renal water conservation (higher urinary
creatinine concentration, osmolality and specific gravity)
compared to those who only required one bolus. These
patients also had a lower CI before induction and a lower
CVP during the bolus infusion procedure (Table 2).
BV expansion exceeded the amount of infused fluid
(Table 1). After the third bolus, BV had increased by 1247
(426) ml in response to 538 (75) ml of starch. A greater
Figure 1 - Stroke volume index (SVI, top) and mean arterial
pressure (MAP, middle) in patients before and after induction of
general anesthesia and after three successive bolus infusions of
hydroxyethyl starch or Ringer’s lactate. The bottom panel shows
the relationship between all incremental changes in SVI andMAP.
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anesthesia-induced drop in MAP was followed by increased
fluid efficiency (r = 0.44, p,0.001). The first fluid bolus had
an exceptionally high efficiency.
Ringer’s lactate
Induction of anesthesia reduced the SVI to 57 (19)% of
baseline. At the end of the three bolus infusions, SVI was at
68 (15)% of baseline (Figure 1). The optimized SVI was also
68 (16)% of baseline (lower than starch, p,0.001).
In patients who received starch, a high initial SVI was
followed by a greater decrease in response to anesthesia and
an optimized SVI that differed from baseline to a greater
extent (Figure 4A).
Compared with 64% of the patients who received starch,
only 20% of the Ringer’s patients responded with an
increase in SVI of $10% in response to the first bolus
infusion (p,0.0001). These fluid responders had higher
urine-specific gravity than did non-responders (mean, 1.023
versus 1.019; p,0.03).
The CVP at the end of the three infusions was lower after
Ringer’s than after starch (median, 6 versus 8 mmHg,
p,0.01), although this parameter did not differ at baseline
(Table 1).
BV expansion exceeded the infused volume (Table 1). The
fluid efficiency for all three boluses was 1.8 (0.6), which
should be compared to 2.3 (0.6) for starch (p,0.0001).
Greater retention was promoted by a pronounced decrease
in the MAP (Figure 4B).
Exploratory analyses
Warranted boluses: A total of 23% of the ‘‘unwarranted’’
starch infusions (i.e., those that did not increase SVI by
$10%) were followed by warranted infusions (Table 1).
Patients in whom several bolus infusions (regardless of
order) increased SVI by $10% had between 14% and 20%
lower SV, SVI, CI and CVP at baseline compared to the
others (all differences between p,0.05 and p,0.01). In
contrast, the MAP at baseline was virtually identical (mean,
103 mmHg).
Oxygen delivery: DO2 at baseline was 1220 ml/min and
decreased both in response to the induction of general
anesthesia and following the later infusion of fluid
(p,0.001). At the end of the first, second and third bolus
infusion, the DO2 values were 671 (210), 635 (203) and 594
(188) ml/min, respectively.
The decrease in DO2 was dependent on fluid responsive-
ness for those in whom none, 1, 2 or 3 boluses were
warranted (i.e., led to an increase in SVI$10%); the mean
decreases in DO2 from the end of the first to the third bolus
were 15%, 10%, 7% and 0%, respectively (ANOVA, p,0.02).
Figure 2 - Stroke volume index (SVI) at baseline versus the relative change in SVI caused by anesthesia and three bolus infusions of
hydroxyethyl starch. Fluid only restored baseline SVI in patients who had a markedly low SVI before the induction.
Figure 3 - The relative change in stroke volume index (SVI) during
fluid volume optimization with starch, which increased SVI by
approximately 20% (top). The optimized SVI had a smaller
variability than did SVI at baseline, i.e., before the induction of
anesthesia (bottom).
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Predictive statistics: All three urine indices (urinary
creatinine $12 mmol/l, specific gravity $1.020 and osmol-
ality $600 mOsmol/kg) had an area under the ROC curve of
0.65-0.70 when used to predict whether several starch boluses
were required to reach the optimized SVI after induction of
general anesthesia (preloaded patients excluded). However,
the optimal cut-off point for urinary creatinine was
$10 mmol/l, which showed a sensitivity of 70% and a
specificity of 71%. The corresponding sensitivity and speci-
ficity values for CI#3.5 l/min/m2 were 70% and 62%, and for
CVP,5 mmHg, they were 50% and 55%, respectively. The
areas under these ROC curves were 0.69, 0.65 and 0.61 for
urinary creatinine, CI and CVP, respectively (Figure 5).
Patients who fulfilled the criteria for dehydration based
on urinary creatinine, CI and CVP had an 83% likelihood of
requiring more than one starch bolus to become SVI
optimized (random likelihood, 54%). The likelihood that
none or only one bolus would be required was 32%.
When a patient had both urinary creatinine $10 mmol/l
and CI#3.5 l/min/m2, the likelihood of requiring more
than one starch bolus or only 0–1 starch bolus were 91% and
46%. When neither of these two criteria was fulfilled, the
percentages were 68% and 9%.
& DISCUSSION
Induction of general anesthesia causes vasodilatation that
reduces venous return, causing SVI and CI to decrease.
Fluid volume optimization performed in this setting merely
served to counteract the drop in SVI that occurred in
response to the induction. In the vast majority of patients,
the optimized SVI (when fluid could no longer increase SVI)
was much lower than the non-optimized SVI measured
before induction (Figure 1, top). It was simply not possible
to create a hyperkinetic hemodynamic state with fluid alone,
which might indicate that anesthesia shifted the Frank-
Starling curve downward. Even full restoration of baseline
SVI was rarely achieved and only occurred in those who
had a low SVI at baseline. Overall, two-thirds of the patients
who received starch were fluid responders, which agrees
with previous findings (7). This proportion is much higher
than that observed in conscious preoperative patients (10).
Neither the hemodynamic reaction to anesthesia induc-
tion nor the fluid efficiency was able to accurately identify
the fluid responder patients (Table 2). Instead, the need for
more than one fluid bolus before reaching the flat segment
of the Frank-Starling curve was associated with discrete
Table 1 - Demographics, hemodynamics and blood volume (BV) expansion. The data are presented according to the
contents of the three successive bolus infusions: hydroxyethyl starch or Ringer’s lactate.
Bolus fluid Starch Starch + preloading Ringer’s lactate ANOVA
Baseline
N 56 30 25
Age (years) 56 (12) 58 (13) 61 (9)
Body weight (kg) 60 (8) 59 (9) 57 (9)
Males (percent) 29 47 28
CI (l/min/m2) 3.8 (1.0) 3.8 (0.8) 3.9 (0.8)
SVI (ml/m2/beat) 50 (16) 49 (9) 54 (9)
MAP (mmHg) 103 (12) 105 (14) 108 (10)
CVP (mmHg) 4.8 (3.4) 5.2 (2.2) 4.9 (2.6)
BV (l) 4.4 (0.7) 4.0 (0.8) 4.1 (0.8)
Bolus infusions
SVI before first bolus/baseline (ratio) 0.67 (0.14) 0.66 (0.18) 0.65 (0.15)
SVI after last bolus/baseline (ratio) 0.86 (0.22) 0.87 (0.21) 0.68 (0.15) p,0.002
MAP before first bolus/baseline (ratio) 0.73 (0.11) 0.72 (0.11) 0.69 (0.11)
MAP after last bolus/baseline (ratio) 0.74 (0.12) 0.74 (0.10) 0.73 (0.14)
Volume of each fluid bolus (ml) 181 (24) 176 (26) 170 (27)
Volume responder (%)
1st bolus 61 70 20 p,0.001
2nd bolus 43 47 13 p,0.01
3rd bolus 23 22 14
Volume optimized (%, cumulative)
After 1st bolus 25 27 74 p,0.001
After 2nd bolus 46 60 81 p,0.002
After 3rd bolus 88 87 89
Increase in SVI (%)
1st bolus 15 (15) 15 (13) 5 (9) p,0.01
2nd bolus 10 (12) 11 (16) 1 (7) p,0.01
3rd bolus 2 (9) 6 (9) 3 (10)
BV expansion (ml)
1st bolus 705 (258) 622 (247) 570 (235) p,0.01
2nd bolus 313 (180) 267 (154) 188 (131) p,0.05
3rd bolus 300 (304) 278 (210) 146 (170)
Fluid efficiency (ratio)
1st bolus 3.9 (1.3) 3.5 (1.3) 3.4 (1.4) p,0.02
2nd bolus 1.8 (1.1) 1.5 (0.8) 1.1 (0.8)
3rd bolus 1.6 (1.5) 1.6 (1.1) 0.9 (1.1)
The data are presented as the mean (SD) or the incidence expressed as a percentage (%). Incidence data were tested using contingency table analysis.
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signs of dehydration and/or hypovolemia in the form of
low CI, SVI and CVP, as well as increased urinary
concentrations of metabolic wastes due to renal water
conservation.
The bolus infusions with starch usually caused progres-
sively weaker SVI increases, which is consistent with the
Frank-Starling law of the heart; the total increase was 20%
for the three bolus infusions in the starch group (Table 1,
Figure 3A). The final effect of the volume optimization was
a clustering of the SVI at approximately 35-40 ml/m2/beat,
whereas patients with hyperkinetic circulation at baseline
tended to achieve somewhat higher values.
Fluid volume optimization with Ringer’s lactate was less
effective. Here, only one-fifth of the patients appeared to be
fluid responders despite the small difference in fluid
efficiency between Ringer’s lactate and starch. In the clinic,
these non-responders would be regarded as being normo-
volemic, although a comparison with the starch patients
suggests that many of them most likely never reached the
top of the Frank-Starling curve. This use of insufficient bolus
volumes can apparently lead to erroneous conclusions
regarding fluid responsiveness.
The same principal relationship between the baseline and
optimized SVI was noted for Ringer’s lactate and for starch
(Figure 4A). Animal experiments revealed that starch, but
not Ringer’s lactate, improved microcirculatory flow and
intestinal oxygenation during fluid volume optimization
(11). However, Yates et al. recently found that gastrointest-
inal morbidity after colorectal surgery did not differ
between patients who received starch and those who
received balanced crystalloid (5). Our data suggest that a
fluid volume larger than 3 ml/kg is needed to challenge
fluid responsiveness when using a crystalloid in bolus
infusions.
Detecting dehydration might be cumbersome in clinical
medicine but might be accompanied by slight reductions
in CI, SVI and possibly CVP. A serum osmolality
$300 mOsmol/kg indicates severe (.5%) water depletion
(12), whereas urine indices, such as creatinine, osmolality
and specific gravity, are capable of revealing dehydration of
only 1% (8,13). The urine sample methodology has been
developed in sports medicine, where changes in body
weight have served as a control.
The cut-off between euhydration and dehydration in
healthy adults up to age 70 has been set at 3% of the body
weight, which corresponds to levels of urinary creatinine
$12 mmol/l, specific gravity $1.020 and osmolality
$600 mOsmol/kg (8). Patients whose urine analysis sur-
passed these limits in our study were more likely to need
several boluses before reaching the top of the Frank-Starling
curve (Table 2, top). Urine analyses were not strong
predictors of fluid responsiveness; however, elevated
urinary creatinine increased the likelihood (from the
random 54% to 70%) that a patient would later require
several starch boluses before becoming SVI optimized. This
percentage increased to 91% if the high urinary creatinine
coexisted with a low CI, which seems to be a strong
indication for taking the time required to perform a series of
bolus infusions to establish the optimized SVI after inducing
general anesthesia. It might be possible to speed up the
volume optimization process by infusing colloid fluid until
the SVI reaches 40 ml/m2/beat, which is the optimized SVI
that most patients achieve. In contrast, the likelihood of
encountering a patient who is markedly fluid responsive is
low if urinary creatinine is low and CI is on the high side
(only 9% of the patients in our study).
The clinical importance of moderately severe dehydration
is not well known in perioperative medicine, although a few
previous studies suggest a link between dehydration and
postoperative complications. Three times as many post-
operative complications were observed in hip fracture
patients who presented a urine specific gravity $1.020
compared with other patients (14). The present study did
not record complications, but preloading with 500 ml of
Table 2 - Urine analysis and hemodynamic responses to three boluses of hydroxyethyl starch. Patients who received
preloading with Ringer’s lactate are not shown.
Parameter 0-1 boluses warranted (N=26) 2–3 boluses warranted (N=30) Mann-Whitney U test
Urine analysis
Osmolality (mOsmol/kg) 536 (439–699) 687 (618–820) p,0.04
Creatinine concentration (mmol/l) 7.2 (4.9–11.8) 12.3 (6.9–20.1) p,0.02
Specific gravity 1.017 (1.015–1.020) 1.020 (1.019–1.025) p,0.04
CI and SVI
CI at baseline (l/min/m2) 4.2 (3.5–4.7) 3.3 (2.9–4.1) p,0.04
CI after three boluses/baseline (ratio) 0.57 (0.48–0.66) 0.71 (0.57–0.82) p,0.02
SVI at baseline (ml/m2/beat) 51 (44–59) 42 (38–55)
SVI after induction/baseline (%) 0.62 (0.55–0.74) 0.59 (0.50–0.71)
SVI after three boluses/baseline (ratio) 0.79 (0.71–0.88) 0.88 (0.80–1.14) p,0.04
Optimal SVI/baseline (ratio) 0.72 (0.64–0.85) 0.92 (0.80–1.13) p,0.01
MAP
MAP at baseline (mmHg) 102 (98–110) 103 (94–109)
MAP after induction/baseline (ratio) 0.73 (0.66–0.78) 0.75 (0.68–0.80)
MAP after three boluses/baseline (ratio) 0.71 (0.63–0.75) 0.75 (0.67–0.83)
CVP
CVP at baseline (mmHg) 5 (4–6) 4 (2–6)
CVP after 1st bolus (mmHg) 7 (6–8) 5 (4–6) p,0.001
CVP after 2nd bolus (mmHg) 8 (7–9) 6 (5–7) p,0.001
CVP after 3rd bolus (mmHg) 9 (8–10) 7 (6–8) p,0.001
BV expansion
BV change after three boluses (l) 1.4 (1.1–1.6) 1.2 (1.1–1.5)
Fluid efficiency of three boluses (ratio) 2.4 (2.1–2.8) 2.4 (2.0–2.9)
The data are presented as medians (25th–75th percentile).
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Ringer’s lactate to prevent dehydration three hours before
the study was insufficient to reduce fluid responsiveness
and, unfortunately, seemed to invalidate the urine testing.
Preloading was not performed in the Ringer’s lactate group,
as both the preloading and volume optimization with
Ringer’s lactate were secondary issues in this study.
The pronounced BV expansion from the fluid boluses
(fluid efficiency) may be related to hemodynamic depression
in response to the induction. Ringer’s lactate is known to
expand the BV by one-third of the infused volume, but BV
expansion is boosted by the arrest of the distribution process
that occurs when a patient becomes hypotensive (15). A
sudden 20% decrease in the MAP stops the distribution
process and the efficiency of crystalloid fluid will be 100%
(15). Capillary refill can be expected to further boost the BV
expansion in the event that the MAP decreases by nearly
30%, as was observed in the present study. The high fluid
efficiency of the first bolus infusion includes the capillary
refill that occurs in response to the induction. However,
capillary refill in this setting, without a fluid infusion, is
modest and dilutes the venous plasma by only 4-7% (16,17).
The fluid efficiency of 6% hydroxyethyl starch 130/0.4
also increased during arterial hypotension, which has not
been previously demonstrated. The fluid efficiency is 1.0 in
normotensive volunteers (18); however, it apparently
increases to 1.5-1.8 during hypotension. As with Ringer’s,
the fluid efficiency was particularly high during the first
bolus infusion.
High fluid efficiency is not only a desired effect but also
counteracts the increase in DO2 expected to result from a
fluid-induced increase in CO. Induction of general anesthe-
sia reduces DO2 due to its depressive effect on CO;
however, the fluid boluses in the present study caused a
further reduction by 15% in the non-responders, whereas
DO2 was unchanged in the responders. This result indicates
that bolus infusions of fluid alone may not be a useful way
to increase DO2, as each incremental increase in CO is equal
to or smaller than the incremental decrease in Hb. Here,
adrenergic drugs would be required to raise DO2 by the 65%
needed to reach Shoemaker’s original target DO2I of
600 ml/(min m2) (3).
The purpose of using a rigid volume optimization
protocol with three straight bolus infusions was to cover
the natural course of the SVI optimization process and to
limit the bedside influence of the researchers as much as
possible. All data were also recorded digitally, which
prevented subjective judgement. Certain findings were
obtained because this protocol was implemented; for
example, 23% of the patients who were already SVI
optimized later proved to be fluid responders. This finding
is a critical issue for those who use stroke volume
monitoring and could be attributed to measurement errors,
variability in sympathetic tone or rheological changes
caused by the infused fluid.
Another issue is that fluid administration in already SVI-
optimized patients reduced DO2. This parameter is greatly
Figure 4 - The relationship between preoperative and optimized
stroke volume index (SVI) in patients receiving Ringer’s lactate
for fluid volume optimization (top). The fluid efficiency of
Ringer’s lactate in these patients was greater when there was a
profound decrease in mean arterial pressure (MAP, bottom).
Figure 5 - ROC curves for urinary creatinine concentration,
urinary osmolality, central venous pressure (CVP) and cardiac
index measured before induction of general anesthesia were
used to predict whether patients would later have to receive
several starch boluses before becoming volume optimized (i.e.,
at least two boluses increased their stroke volume by$10%). The
cardiac index is below the reference line, as low values imply a
higher likelihood.
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influenced by the fluid-induced reciprocal relationship
between Hb and CO. The high efficiency of fluid infused
after the induction of general anesthesia must be matched
by a strong increase in CO (and thereby in SVI) to maintain
DO2. When CO does not increase, as in fluid non-
responders, a decrease in DO2 occurs. This response must
be considered as a risk when infusing fluid without SVI
monitoring.
The present study fills a knowledge gap, as virtually all
previous studies begin SV monitoring when general
anesthesia has already been induced. Limitations include
the fact that central hemodynamics were measured using
FloTrac/Vigileo, which uses an internal calibration with a
higher coefficient of variation compared with that of other
arterial waveform pulse contour modes. CO is calculated
from arterial pressure, age, gender and a conversion factor
based on the skewness and kurtosis of the arterial waveform
and on estimates of the vascular compliance and resistance.
CO obtained in this way depends less on cardio-pulmonary
interactions than on stroke volume variation and pulse
pressure variation, which require that patients are mechani-
cally ventilated. The agreement between FloTrac/Vigileo
and other methods of measuring CO is considered to be
good (19) also during spontaneous breathing (20), although
its accuracy and precision in hemodynamically unstable
patients remain uncertain.
The value of urine sampling to detect dehydration has
been validated against a known deficit in body water in
healthy humans but not in those with severe disease.
Therefore, patients from ASA class III were not included in
this study.
Arterial blood is a better measure of whole-body
hemodilution than is peripheral venous blood. Arterial
blood shows slightly greater hemodilution than venous
blood during infusion of Ringer’s lactate, but the arteriove-
nous difference should dissipate 5 min after the infusion
ends (21).
Finally, the patients were studied in blocks of 25-30 and
not randomized individually. Patients in the starch group
were later randomized to receive either starch or Ringer’s
lactate during the actual surgery and the results of these
experiments will be reported elsewhere.
In conclusion, evidence of dehydration in central hemo-
dynamic parameters and urine samples prior to induction
was followed by an increased probability of fluid respon-
siveness before the commencement of surgery. The SVI
averaged 40 ml/m2/beat when the patients were opti-
mized. The bolus infusion volume of Ringer’s lactate must
be larger than 3 ml/kg to effectively increase the stroke
volume.
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